Combination of two compounds shows promise in the lab

Novartis supports promising young scientists who want to improve their chances to attain advanced science degrees.

Novartis researchers are learning how a novel approach to immunotherapy could help treat cancer.

We’re working to bring the hope of advanced medicine to more patients.

Immunotherapy for cancer is on the brink of breakthroughs. Learn how NIBR have high expectations for this medical science.

Thierry Diagana and Jonathan Spector from the Novartis Institute for Tropical Diseases (NITD) discuss learnings about their work in Neglected Tropical Diseases (NTDs) and share insights into the factors, which could lead to a resurgence of these diseases.

Novartis researchers aim to quash inflammation to treat chronic disease.

An essay by Vas Narasimhan, CEO of Novartis about the historical context and coming innovations in medicine with an introduction by Goran Mijuk.